(Post-pandemic Era)-Global The Induced Pluripotent Stem Cells (iPSCs) Market Segment Research Report 2024

Report ID: 875299 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global The Induced Pluripotent Stem Cells (iPSCs) Market Segment Research Report 2021
1. Research Scope
2. Market Overview
    2.1 Product Introduction, Application, Picture
    2.2 Global The Induced Pluripotent Stem Cells (iPSCs) Market by Value
      2.2.1 Global The Induced Pluripotent Stem Cells (iPSCs) Revenue by Type
      2.2.2 Global The Induced Pluripotent Stem Cells (iPSCs) Market by Value (%)
    2.3 Global The Induced Pluripotent Stem Cells (iPSCs) Market by Production
      2.3.1 Global The Induced Pluripotent Stem Cells (iPSCs) Production by Type
      2.3.2 Global The Induced Pluripotent Stem Cells (iPSCs) Market by Production (%)

3. The Major Driver of The Induced Pluripotent Stem Cells (iPSCs) Industry
    3.1 Historical & Forecast Global The Induced Pluripotent Stem Cells (iPSCs) Demand
    3.2 Largest Application for The Induced Pluripotent Stem Cells (iPSCs) (2017-2027)
    3.3 The Major Downstream Company in China Market 2021

4. Global and Regional The Induced Pluripotent Stem Cells (iPSCs) Market
    4.1 Regional Market Size in Terms of Production & Demand (2021)
    4.2 Regional Market Share in Terms of Revenue (2019-2027) 
    4.3 Concentration Ratio (CR5& CR10) of The Induced Pluripotent Stem Cells (iPSCs) Market
    4.4 Mergers & Acquisitions, Expansion Plans

5. US The Induced Pluripotent Stem Cells (iPSCs) Production, Demand (2017-2027)
    5.1 Current and Estimated Production Breakdown by Type
    5.2 Current and Estimated Demand Breakdown by Type
    5.3 Current and Estimated Demand Breakdown by Application
    5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe The Induced Pluripotent Stem Cells (iPSCs) Production, Demand (2017-2027)
    6.1 Current and Estimated Production Breakdown by Type
    6.2 Current and Estimated Demand Breakdown by Type
    6.3 Current and Estimated Demand Breakdown by Application
    6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China The Induced Pluripotent Stem Cells (iPSCs) Production, Demand (2017-2027)
    7.1 Current and Estimated Production Breakdown by Type
    7.2 Current and Estimated Demand Breakdown by Type
    7.3 Current and Estimated Demand Breakdown by Application
    7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan The Induced Pluripotent Stem Cells (iPSCs) Production, Demand (2017-2027)
    8.1 Current and Estimated Production Breakdown by Type
    8.2 Current and Estimated Demand Breakdown by Type
    8.3 Current and Estimated Demand Breakdown by Application
    8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India The Induced Pluripotent Stem Cells (iPSCs) Production, Demand (2017-2027)
    9.1 Current and Estimated Production Breakdown by Type
    9.2 Current and Estimated Demand Breakdown by Type
    9.3 Current and Estimated Demand Breakdown by Application
    9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea The Induced Pluripotent Stem Cells (iPSCs) Production, Demand (2017-2027)
    10.1 Current and Estimated Production Breakdown by Type
    10.2 Current and Estimated Demand Breakdown by Type
    10.3 Current and Estimated Demand Breakdown by Application
    10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia The Induced Pluripotent Stem Cells (iPSCs) Production, Demand (2017-2027)
    11.1 Current and Estimated Production Breakdown by Type
    11.2 Current and Estimated Demand Breakdown by Type
    11.3 Current and Estimated Demand Breakdown by Application
    11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global The Induced Pluripotent Stem Cells (iPSCs) Average Price Trend
    12.1 Market Price for Each Type of The Induced Pluripotent Stem Cells (iPSCs) in US (2017-2021)
    12.2 Market Price for Each Type of The Induced Pluripotent Stem Cells (iPSCs) in Europe (2017-2021)
    12.3 Market Price for Each Type of The Induced Pluripotent Stem Cells (iPSCs) in China (2017-2021)
    12.4 Market Price for Each Type of The Induced Pluripotent Stem Cells (iPSCs) in Japan (2017-2021)
    12.5 Market Price for Each Type of The Induced Pluripotent Stem Cells (iPSCs) in India (2017-2021)
    12.6 Market Price for Each Type of The Induced Pluripotent Stem Cells (iPSCs) in Korea (2017-2021)
    12.7 Market Price for Each Type of The Induced Pluripotent Stem Cells (iPSCs) in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
    13.1 The Induced Pluripotent Stem Cells (iPSCs) Industrial Chain Analysis
    13.2 Downstream
    13.3 Impact of COVID-19
    13.4 Technology Trends of The Induced Pluripotent Stem Cells (iPSCs)

14. The Induced Pluripotent Stem Cells (iPSCs) Competitive Landscape
     14.1 Fujifilm Holding Corporation (CDI)
        14.1.1 Fujifilm Holding Corporation (CDI) Company Profiles
        14.1.2 Fujifilm Holding Corporation (CDI) Product Introduction
        14.1.3 Fujifilm Holding Corporation (CDI) The Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue (2017-2021)
        14.1.4 Strategic initiatives
     14.2 ReproCELL
        14.2.1 ReproCELL Company Profiles
        14.2.2 ReproCELL Product Introduction
        14.2.3 ReproCELL The Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue (2017-2021)
        14.2.4 Strategic initiatives
     14.3 Astellas Pharma Inc
        14.3.1 Astellas Pharma Inc Company Profiles
        14.3.2 Astellas Pharma Inc Product Introduction
        14.3.3 Astellas Pharma Inc The Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue (2017-2021)
        14.3.4 Strategic initiatives
     14.4 Ncardia
        14.4.1 Ncardia Company Profiles
        14.4.2 Ncardia Product Introduction
        14.4.3 Ncardia The Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue (2017-2021)
        14.4.4 Strategic initiatives
     14.5 Cell Inspire Biotechnology
        14.5.1 Cell Inspire Biotechnology Company Profiles
        14.5.2 Cell Inspire Biotechnology Product Introduction
        14.5.3 Cell Inspire Biotechnology The Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue (2017-2021)
        14.5.4 Strategic initiatives
     14.6 Sumitomo Dainippon Pharma
        14.6.1 Sumitomo Dainippon Pharma Company Profiles
        14.6.2 Sumitomo Dainippon Pharma Product Introduction
        14.6.3 Sumitomo Dainippon Pharma The Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue (2017-2021)
        14.6.4 Strategic initiatives
     14.7 Pluricell Biotech
        14.7.1 Pluricell Biotech Company Profiles
        14.7.2 Pluricell Biotech Product Introduction
        14.7.3 Pluricell Biotech The Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue (2017-2021)
        14.7.4 Strategic initiatives
     14.8 Fate Therapeutics, Inc
        14.8.1 Fate Therapeutics, Inc Company Profiles
        14.8.2 Fate Therapeutics, Inc Product Introduction
        14.8.3 Fate Therapeutics, Inc The Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue (2017-2021)
        14.8.4 Strategic initiatives
15. Conclusion


List of Tables and Figures

    Figure 1. Total Demand by Application of The Induced Pluripotent Stem Cells (iPSCs) Industry (Volume)
    Figure 2. The Induced Pluripotent Stem Cells (iPSCs) Production & Demand by Regions in 2021
    Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
    Figure 4. The Top 10 and 5 Players Market Share by The Induced Pluripotent Stem Cells (iPSCs) Revenue in 2021
    Figure 5. US The Induced Pluripotent Stem Cells (iPSCs) Production, Demand (2017-2027)
    Figure 6. Production Breakdown by Type (%)
    Figure 7. Demand Breakdown by Type (%)
    Figure 8. Demand Breakdown by Application (%)
    Figure 9. Revenue Breakdown by Type (%)
    Figure 10. Revenue Breakdown by Application (%)
    Figure 11. Europe The Induced Pluripotent Stem Cells (iPSCs) Production, Demand (2017-2027)
    Figure 12. Production Breakdown by Type (%)
    Figure 13. Demand Breakdown by Type (%)
    Figure 14. Demand Breakdown by Application (%)
    Figure 15. Revenue Breakdown by Type (%)
    Figure 16. Revenue Breakdown by Application (%)
    Figure 17. China The Induced Pluripotent Stem Cells (iPSCs) Production, Demand (2017-2027)
    Figure 18. Production Breakdown by Type (%)
    Figure 19. Demand Breakdown by Type (%)
    Figure 20. Demand Breakdown by Application (%)
    Figure 21. Current and Estimated Revenue Breakdown by Type
    Figure 22. Revenue Breakdown by Type (%)
    Figure 23. Revenue Breakdown by Application (%)
    Figure 24. Japan The Induced Pluripotent Stem Cells (iPSCs) Production, Demand (2017-2027)
    Figure 25. Production Breakdown by Type (%)
    Figure 26. Demand Breakdown by Type (%)
    Figure 27. Demand Breakdown by Application (%)
    Figure 28. Revenue Breakdown by Type (%)
    Figure 29. Revenue Breakdown by Application (%)
    Figure 30. India The Induced Pluripotent Stem Cells (iPSCs) Production, Demand (2017-2027)
    Figure 31. Production Breakdown by Type (%)
    Figure 32. Demand Breakdown by Type (%)
    Figure 33. Demand Breakdown by Application (%)
    Figure 34. Revenue Breakdown by Type (%)
    Figure 35. Revenue Breakdown by Application (%)
    Figure 36. Korea The Induced Pluripotent Stem Cells (iPSCs) Production, Demand (2017-2027)
    Figure 37. Production Breakdown by Type (%)
    Figure 38. Demand Breakdown by Type (%)
    Figure 39. Demand Breakdown by Application (%)
    Figure 40. Revenue Breakdown by Type (%)
    Figure 41. Revenue Breakdown by Application (%)
    Figure 42. Southeast Asia The Induced Pluripotent Stem Cells (iPSCs) Production, Demand (2017-2027)
    Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
    Figure 44. Production Breakdown by Type (%)
    Figure 45. Demand Breakdown by Type (%)
    Figure 46. Revenue Breakdown by Type (%)
    Figure 47. Revenue Breakdown by Application (%)
    Figure 48. Industrial Chain
    Table 1. Top Manufacturers and Market Segmentation
    Table 2. Product Introduction, Application, Picture
    Table 3. The Induced Pluripotent Stem Cells (iPSCs) Revenue, by Type (Million USD) (2017-2027)
    Table 4. The Induced Pluripotent Stem Cells (iPSCs) Production, by Type (K Unit) (2017-2027)
    Table 5. The Induced Pluripotent Stem Cells (iPSCs) Demand (K Unit) by Application (2017-2027)
    Table 6. The Induced Pluripotent Stem Cells (iPSCs) Demand (Million USD) by Application (2017-2027)
    Table 7. The Major Downstream Company in China
    Table 8. Regional Market Share in Terms of Production & Demand (2021)
    Table 9. Regional Market Share in Terms of Revenue (2021&2027)
    Table 10. Ranking of Global Top The Induced Pluripotent Stem Cells (iPSCs) Companies by Revenue, Concentration Ratio in 2021
    Table 11. Mergers & Acquisitions, Expansion Plans
    Table 12. US The Induced Pluripotent Stem Cells (iPSCs) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 16. Current and Estimated Revenue Breakdown by Type
    Table 17. Current and Estimated Revenue Breakdown by Application
    Table 18. Europe The Induced Pluripotent Stem Cells (iPSCs) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 22. Current and Estimated Revenue Breakdown by Type
    Table 23. Current and Estimated Revenue Breakdown by Application
    Table 24. China The Induced Pluripotent Stem Cells (iPSCs) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 25. Table Current and Estimated Production Breakdown by Type
    Table 26. Current and Estimated Demand Breakdown by Type
    Table 27. Current and Estimated Demand Breakdown by Application
    Table 28. Current and Estimated Revenue Breakdown by Application
    Table 29. Japan The Induced Pluripotent Stem Cells (iPSCs) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 33. Current and Estimated Revenue Breakdown by Type
    Table 34. Current and Estimated Revenue Breakdown by Application
    Table 35. India The Induced Pluripotent Stem Cells (iPSCs) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 39. Current and Estimated Revenue Breakdown by Type
    Table 40. Current and Estimated Revenue Breakdown by Application
    Table 41. Korea The Induced Pluripotent Stem Cells (iPSCs) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 45. Current and Estimated Revenue Breakdown by Type
    Table 46. Current and Estimated Revenue Breakdown by Application
    Table 47. Southeast Asia The Induced Pluripotent Stem Cells (iPSCs) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 50. Current and Estimated Revenue Breakdown by Type
    Table 51. Current and Estimated Revenue Breakdown by Application
    Table 52. Market Price (USD/Unit) for Each Type of The Induced Pluripotent Stem Cells (iPSCs) in US (2017-2021)
    Table 53. Market Price (USD/Unit) for Each Type of The Induced Pluripotent Stem Cells (iPSCs) in Europe (2017-2021)
    Table 54. Market Price (USD/Unit) for Each Type of The Induced Pluripotent Stem Cells (iPSCs) in China (2017-2021)
    Table 55. Market Price (USD/Unit) for Each Type of The Induced Pluripotent Stem Cells (iPSCs) in Japan (2017-2021)
    Table 56. Market Price (USD/Unit) for Each Type of The Induced Pluripotent Stem Cells (iPSCs) in India (2017-2021)
    Table 57. Market Price (USD/Unit) for Each Type of The Induced Pluripotent Stem Cells (iPSCs) in Korea (2017-2021)
    Table 58. Market Price (USD/Unit) for Each Type of The Induced Pluripotent Stem Cells (iPSCs) in Southeast Asia (2017-2021)
    Table 59. Key Downstream Customer in Each Application Field
    Table 60. Fujifilm Holding Corporation (CDI) Profiles
    Table 61. Fujifilm Holding Corporation (CDI) The Induced Pluripotent Stem Cells (iPSCs) Product Introduction
    Table 62. Fujifilm Holding Corporation (CDI) The Induced Pluripotent Stem Cells (iPSCs) Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 63. Fujifilm Holding Corporation (CDI) Strategic initiatives
    Table 64. ReproCELL Profiles
    Table 65. ReproCELL The Induced Pluripotent Stem Cells (iPSCs) Product Introduction
    Table 66. ReproCELL The Induced Pluripotent Stem Cells (iPSCs) Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 67. ReproCELL Strategic initiatives
    Table 68. Astellas Pharma Inc Profiles
    Table 69. Astellas Pharma Inc The Induced Pluripotent Stem Cells (iPSCs) Product Introduction
    Table 70. Astellas Pharma Inc The Induced Pluripotent Stem Cells (iPSCs) Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 71. Astellas Pharma Inc Strategic initiatives
    Table 72. Ncardia Profiles
    Table 73. Ncardia The Induced Pluripotent Stem Cells (iPSCs) Product Introduction
    Table 74. Ncardia The Induced Pluripotent Stem Cells (iPSCs) Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 75. Ncardia Strategic initiatives
    Table 76. Cell Inspire Biotechnology Profiles
    Table 77. Cell Inspire Biotechnology The Induced Pluripotent Stem Cells (iPSCs) Product Introduction
    Table 78. Cell Inspire Biotechnology The Induced Pluripotent Stem Cells (iPSCs) Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 79. Cell Inspire Biotechnology Strategic initiatives
    Table 80. Sumitomo Dainippon Pharma Profiles
    Table 81. Sumitomo Dainippon Pharma The Induced Pluripotent Stem Cells (iPSCs) Product Introduction
    Table 82. Sumitomo Dainippon Pharma The Induced Pluripotent Stem Cells (iPSCs) Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 83. Sumitomo Dainippon Pharma Strategic initiatives
    Table 84. Pluricell Biotech Profiles
    Table 85. Pluricell Biotech The Induced Pluripotent Stem Cells (iPSCs) Product Introduction
    Table 86. Pluricell Biotech The Induced Pluripotent Stem Cells (iPSCs) Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 87. Pluricell Biotech Strategic initiatives
    Table 88. Fate Therapeutics, Inc Profiles
    Table 89. Fate Therapeutics, Inc The Induced Pluripotent Stem Cells (iPSCs) Product Introduction
    Table 90. Fate Therapeutics, Inc The Induced Pluripotent Stem Cells (iPSCs) Sales (Unit), Revenue (Million USD) (2017-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global The Induced Pluripotent Stem Cells Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global The Induced Pluripotent Stem Cells Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global The Induced Pluripotent Stem Cells Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports